ArticleImmunotherapy2020

How COVID-19 affects patients receiving anticytokine and JAK inhibitors in rheumatology and dermatology.

Ting Yi Jessica Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.